Efficacy of gastric bypass in the treatment of obesity-associated carbohydrate metabolism disorders

Abstract

We have operated on 42 patients ages 22 to62 suffering different forms of obesity and obesity-related metabolic disorders. Body mass indexes have ranged from 28 to 62 kg/m2. All patients have had symptoms of metabolic disorders of different intensity. Our goal has been exerting maximal influence on carbohydrate metabolism processes rather than mere body weight reduction. The patients have undergone sleeve gastrectomy, laparoscopic mini-gastric bypass, Roux en Y gastric bypass, as well as modified gastric bypass with Rouxen Y gastrectomy with a 180-cm bypass and 70-cm alimentary loop as an independent way of surgical treatment of diabetes type 2 associated with obesity. Sleeve gastrectomy in terms of weight control has demonstrated a 73% efficacy, and gastric bypass –a 89% efficacy. The efficacy of surgeries in patients with carbohydrate metabolism disorders through Roux en Y gastric bypass has totaled 96%,classic Roux en Y gastric bypass-92%, sleeve gastrectomy – 60%. Roux en Y gastric bypass andmini-gastric bypass are more effective in the treatment of obesity and associated metabolic disorders compared to sleeve gastrectomy. Gastric bypass has proved effective even in diabetes patients with body mass indexes up to 30 kg/m2.